Evidence map›Paper›PMID 21430162›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Cleavage of the vesicular GABA transporter under excitotoxic conditions is followed by accumulation of the truncated transporter in nonsynaptic sites.

João R Gomes, Andrea C Lobo, Carlos V Melo, Ana R Inácio, Jiro Takano, Nobuhisa Iwata, Takaomi C Saido, Luís P de Almeida, Tadeusz Wieloch, Carlos B Duarte

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Therapeutic effect of transmembrane TAT-tCNTF via Erk and Akt activation usingInternational journal of clinical and experimental pathology · 2018
    Article
  11. Article
  12. Downregulation of GABAMolecular neurobiology · 2017
    Article
  13. Article
  14. Article
  15. Insulin neuroprotection and the mechanisms.Chinese medical journal · 2015
    Review
  16. Article
  17. Article
  18. Review
  19. Sorting of the vesicular GABA transporter to functional vesicle pools by an atypical dileucine-like motif.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  20. Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

João R GomesCenter for Neuroscience and Cell Biology, Department of Life Sciences, University of Coimbra, 3004-517 Coimbra, Portugal.
Andrea C Lobo
Carlos V Melo
Ana R Inácio
Jiro Takano
Nobuhisa Iwata
Takaomi C Saido
Luís P de Almeida
Tadeusz Wieloch
Carlos B Duarte
RIKEN Center for Brain Science · JPCentro de Neurociências e Biologia CelularCenter for Neurosciences · USLund University · SEUniversity of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GABA is the major inhibitory neurotransmitter in the CNS and changes in GABAergic neurotransmission affect the overall activity of neuronal networks. The uptake of GABA into synaptic vesicles is mediated by the vesicular GABA transporter (VGAT), and changes in the expression of the transporter directly regulate neurotransmitter release. In this work we investigated the changes in VGAT protein levels during ischemia and in excitotoxic conditions, which may affect the demise process. We found that VGAT is cleaved by calpains following excitotoxic stimulation of hippocampal neurons with glutamate, giving rise to a stable truncated cleavage product (tVGAT). VGAT cleavage was also observed after transient middle cerebral artery occlusion in mice, a cerebral ischemia model, and following intrahippocampal injection of kainate, but no effect was observed in transgenic mice overexpressing calpastatin, a calpain inhibitor. Incubation of isolated cerebrocortical synaptic vesicles with recombinant calpain also induced the cleavage of VGAT and formation of stable tVGAT. Immunoblot experiments using antibodies targeting different regions of VGAT and N-terminal sequencing analysis showed that calpain cleaves the transporter in the N-terminal region, at amino acids 52 and 60. Immunocytochemistry of GABAergic striatal neurons expressing GFP fusion proteins with the full-length VGAT or tVGAT showed that cleavage of the transporter induces a loss of synaptic delivery, leading to a homogeneous distribution of the protein along neurites. Our results show that excitotoxicity downregulates full-length VGAT, with a concomitant generation of tVGAT, which is likely to affect GABAergic neurotransmission and may influence cell death during ischemia.

Indexed as

AnimalsBlotting, WesternBrain IschemiaCalpainDNAExcitatory Amino Acid AgonistsFemalegamma-Aminobutyric AcidImmunohistochemistryInfarction, Middle Cerebral ArteryKainic AcidLong-Term PotentiationMiceMice, Inbred C57BLNeurotoxinsPC12 CellsCalpainDNAExcitatory Amino Acid Agonistsgamma-Aminobutyric AcidKainic AcidNeurotoxinsPhosphoric Monoester HydrolasesRNA, MessengerVesicular Glutamate Transport Proteins

Identifiers

PMID21430162
PMCPMC6622902
OpenAlexW1995733166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.